# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5.2
**Paper:** paper.pdf
**Timestamp:** 2026-02-26T18:25:50.926741
**Route:** OpenRouter + LaTeX
**Paper Hash:** 9816197b5057becc
**Tokens:** 20470 in / 1331 out
**Response SHA256:** 3dd3cd390c1cc278

---

## 1) Data–Design Alignment (critical)

**Treatment timing vs. data coverage:**  
- Treatment is defined as **Post = 1 from 2016-Q3 onward** (Brexit referendum June 23, 2016).  
- DVF data are stated to cover **2014–2023 (2014-Q1 to 2023-Q4)**.  
✅ No timing impossibility (treatment occurs within the data window; there is ample post-treatment period).

**Post-treatment observations by cohort / support:**  
- Design is continuous-treatment DiD with a single shock date; not staggered adoption. Post-period exists through 2023-Q4.  
- Triple-difference uses both property types (houses/apartments). No indication of missing one side “by construction.”  
✅ No fatal support problem indicated.

**Treatment definition consistency across tables/specs:**  
- Post is consistently described as starting **2016-Q3** in the identification section and used throughout results/tables.  
- Exposure measures (SCI(UK), UK Stock 2016, residualized SCI(UK), SCI(DE)) appear consistently named and used in Tables 2–8.  
✅ No internal mismatch detected (e.g., no conflicting “first treated year” definitions).

## 2) Regression Sanity (critical)

Scanned the regression-result tables for impossible/obviously broken output:

- **Table 2 (Main Results):** coefficients and SEs are in reasonable ranges for a log price outcome; no gigantic SEs, no NA/Inf, and within R² values are between 0 and 1.  
- **Table 3 (Triple-Diff):** coefficients/SEs are modest; within R² is tiny but valid; no impossible values.  
- **Table 4 (Pre-2020 Triple-Diff):** tiny within R² values but still valid (nonnegative, < 1).  
- **Table 5 (Placebo battery):** reports coefficients and p-values (not SEs). No impossible numeric values shown.  
- **Table 6 (Commune-level triple-diff):** coefficients/SEs look plausible; N is large; no impossible values.  
- **Table 7 (Robustness):** coefficients/SEs plausible; within R² valid.  
- **Table 8 (Exchange rate):** coefficients/SEs plausible; within R² valid.

✅ No fatal regression sanity flags (no NA/NaN/Inf, no negative SEs, no R² outside [0,1], no absurd magnitudes).

## 3) Completeness (critical)

- All main regression tables report **standard errors** and **Observations (N)**.  
- No obvious placeholders like **TBD/TODO/XXX/NA** in tables.  
- Figures are referenced and have LaTeX `\includegraphics{...}` calls and `\label{...}`. From source alone I cannot verify that the PDF files exist in the submission package, but there is no internal LaTeX placeholder suggesting missing figures/tables.  
- Methods described (event studies, bootstrap, placebo battery, HonestDiD, commune-level) all have corresponding tables/figures referenced.

✅ No fatal incompleteness detected in the provided source.

## 4) Internal Consistency (critical)

- Sample period and unit counts are consistent where they need to be: 2014–2023 is 40 quarters; the paper explains missing cells leading to fewer than 96×40 observations (3,510 vs 3,840), which is internally coherent.  
- Census-stock restriction to 89 departments is consistently reflected in the **N=3,209** (Table 2/7) and **N=6,412** (Table 3).  
- Key textual claims match tables where checkable (e.g., German triple-diff placebo “p > 0.6” aligns with Table 3 col (4): 0.0075 with SE 0.0174 → p≈0.67).

✅ No fatal internal contradiction found that would make the empirical design impossible or the results tabled inconsistent with stated specs.

ADVISOR VERDICT: PASS